𝔖 Bobbio Scriptorium
✦   LIBER   ✦

MARGINAL ANALYSIS OF RECURRENT EVENTS AND A TERMINATING EVENT

✍ Scribed by RICHARD J. COOK; JERALD F. LAWLESS

Publisher
John Wiley and Sons
Year
1997
Tongue
English
Weight
278 KB
Volume
16
Category
Article
ISSN
0277-6715

No coin nor oath required. For personal study only.

✦ Synopsis

Chronic medical conditions are often manifested by the incidence of recurrent adverse clinical events. In clinical trials designed to investigate therapeutic interventions for such conditions it is natural to make treatment comparisons on the basis of event occurrence. However, when there is a more serious, possibly related, event that terminates the occurrence of the recurrent events, the problem of dependent censoring arises. Here, we consider robust modelling strategies for expressing covariate effects on the recurrent event process that address the possible dependence between the recurrent and terminal events. The various methods differ in the way the dependence is addressed, and hence in the interpretation of covariate effects. The methods are applied to a data set from a kidney transplant study and simulated data chosen for illustrative purposes.

πŸ“œ SIMILAR VOLUMES

rhDNase as an example of recurrent event
rhDNase as an example of recurrent event analysis
✍ Terry M. Therneau; Scott A. Hamilton πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 172 KB πŸ‘ 1 views

We consider counting process methods for analysing time-to-event data with multiple or recurrent outcomes, using the models developed by Anderson and Gill, Wei, Lin and Weissfeld and Prentice, Williams and Peterson. We compare the methods, and show how to implement them using popular statistical sof

USE OF THE WEI–LIN–WEISSFELD METHOD FOR
USE OF THE WEI–LIN–WEISSFELD METHOD FOR THE ANALYSIS OF A RECURRING AND A TERMINATING EVENT
✍ QIAN H. LI; STEPHEN W. LAGAKOS πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 281 KB πŸ‘ 1 views

We consider application of the Wei-Lin-Weissfeld (WLW) method for multiple failure time data when analysing a disease process consisting of a recurring outcome, such as clinical progression, and a terminating outcome, such as death. In order to adapt WLW for this situation, 'events' must be specifie